Axsome Therapeutics Inc (NASDAQ:AXSM)
| 67.84 BATS BZX Real-Time Price As of 11:13am ET |  -0.50 / -0.73%Today’s Change | 35.44 Today|||52-Week Range 109.53 | -16.73% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 3.5K | 20.5K | 42.6K | 48.9K | ||
| Operating Expenses | Gross Income | -3.5K | -20.5K | -42.6K | -48.9K | |
| General Expenses | 9.2M | 27.5M | 27.1M | 32.8M | ||
| Research And Development | 6.8M | 21.2M | 20.0M | 23.5M | ||
| Total Operating Expenses | 9.2M | 27.5M | 27.2M | 32.8M | ||
| Non-Operating Expenses | Operating Income | -9.2M | -27.5M | -27.2M | -32.8M | |
| Extraordinary Credit | 166.3K | 0.00 | 0.00 | 2.8M | ||
| Extraordinary Charge | -2.4M | 0.00 | -646.0K | 0.00 | ||
| Interest Expense On Debt | 0.00 | 132.4K | 1.3M | 1.1M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -10.6M | -27.7M | -29.2M | -31.2M | |
| Income Taxes | 0.00 | -474.3K | -207.1K | -217.4K | ||
| Net Income | -10.6M | -27.2M | -28.9M | -31.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 11.9M | 19.2M | 22.8M | 26.9M | |
| Shares To Calculate EPS Diluted | 11.9M | 19.2M | 22.8M | 26.9M | ||
| Earnings Per Share | EPS | -$0.88 | -$1.42 | -$1.27 | -$1.15 | |
| EPS Diluted | -$0.88 | -$1.42 | -$1.27 | -$1.15 | ||
